{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:36:52Z","timestamp":1788691012256,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018386","name":"Societ\u00e0 Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking agent antagonists in patients undergoing lung surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Seventy patients were randomized in three Italian centers to receive sugammadex or neostigmine at the end of thoracic surgery according to the depth of the residual neuromuscular block. The primary outcome was the time from reversal administration to a train-of-four ratio (TOFR) of 0.9. Secondary outcomes were the time to TOFR of 1.0, to extubation, to postanesthesia unit (PACU) discharge, postoperative complications until 30\u00a0days after surgery, and  length of hospital stay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Median time to recovery to a TOFR of 0.9 was significantly shorter in the sugammadex group compared to the neostigmine one (88 vs. 278\u00a0s \u2014 <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The percentage of patients who recovered to a TOFR of 0.9 within 5\u00a0min from reversal administration was 94.4% and 58.8% in the sugammadex and neostigmine groups, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The time to extubation, but not the PACU stay time, was significantly shorter in the sugammadex group. No differences were found between the study groups as regards postoperative complications and length of hospital stay. The superiority of sugammadex in shortening the recovery time was confirmed for both deep\/moderate and shallow\/minimal neuromuscular block.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Among patients undergoing thoracic surgery, sugammadex ensures a faster recovery from the neuromuscular block and earlier extubation compared to neostigmine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s44158-024-00146-6","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T14:03:42Z","timestamp":1707401022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-1891","authenticated-orcid":false,"given":"Federico","family":"Piccioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio L.","family":"Rosboch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Proto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Ceraolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pierconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Vernocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Valenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Della","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"146_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00000542-200502000-00005","volume":"102","author":"MS Arbous","year":"2005","unstructured":"Arbous MS, Meursing AEE, van Kleef JW et al (2005) Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 102:257\u2013268","journal-title":"Anesthesiology"},{"key":"146_CR2","doi-asserted-by":"crossref","unstructured":"Della Rocca G, Vetrugno L, Coccia C et al (2016) Preoperative evaluation of patients undergoing lung resection surgery: defining the role of the anesthesiologist on a multidisciplinary team. J Cardiothorac Vasc Anesth 30:530\u2013538","DOI":"10.1053\/j.jvca.2015.11.018"},{"key":"146_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1378\/chest.118.5.1263","volume":"118","author":"F Stephan","year":"2000","unstructured":"Stephan F (2000) Pulmonary complications following lung resection. A comprehensive analysis of incidence and possible risk factors. Chest 118:1263\u20131270","journal-title":"Chest"},{"key":"146_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1067\/mtc.2001.114350","volume":"121","author":"A Bernard","year":"2001","unstructured":"Bernard A, Deschamps C, Allen MS et al (2001) Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thoracic Cardiovasc Surg 121:1076\u20131082","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"146_CR5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.athoracsur.2005.11.048","volume":"81","author":"MJ Licker","year":"2006","unstructured":"Licker MJ, Widikker I, Robert J et al (2006) Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thoracic Surg 81:1830\u20131837","journal-title":"Ann Thoracic Surg"},{"key":"146_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/thx.2009.123083","volume":"65","author":"P Agostini","year":"2010","unstructured":"Agostini P, Cieslik H, Rathinam S et al (2010) Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax 65:815\u2013818","journal-title":"Thorax"},{"key":"146_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","volume":"107","author":"GS Murphy","year":"2008","unstructured":"Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS (2008) Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 107:130\u2013137","journal-title":"Anesth Analg"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/bja\/85.6.856","volume":"85","author":"TM Hemmerling","year":"2000","unstructured":"Hemmerling TM, Schmidt J, Hanusa C, Wolf T, Schmitt H (2000) Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth 85:856\u2013860","journal-title":"Br J Anaesth"},{"key":"146_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00540-008-0666-7","volume":"22","author":"Y Saitoh","year":"2008","unstructured":"Saitoh Y, Oshima T, Nakata Y (2008) Monitoring of vecuronium-induced neuromuscular blockade during one-lung ventilation. J Anesth 22:378\u2013384","journal-title":"J Anesth"},{"key":"146_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/EJA.0b013e32833d56b7","volume":"27","author":"M Blobner","year":"2010","unstructured":"Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME (2010) Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 27:874\u2013881","journal-title":"Eur J Anaesthesiol"},{"key":"146_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1365-2044.2012.07197.x","volume":"67","author":"G Geldner","year":"2012","unstructured":"Geldner G, Niskanen M, Laurila P et al (2012) A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. Anaesthesia 67:991\u2013998","journal-title":"Anaesthesia"},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","volume":"109","author":"RK Jones","year":"2008","unstructured":"Jones RK, Caldwell JE, Brull SJ, Soto RG (2008) Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 109:816\u2013824","journal-title":"Anesthesiology"},{"key":"146_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"146_CR14","first-page":"767","volume":"78","author":"G Della Rocca","year":"2012","unstructured":"Della Rocca G, Iannuccelli F, Pompei L, Pietropaoli P, Reale C, Di Marco P (2012) Neuromuscular block in Italy: a survey of current management. Minerva Anestesiol 78:767\u2013773","journal-title":"Minerva Anestesiol"},{"key":"146_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(20)31787-6","volume":"396","author":"A van Dorn","year":"2020","unstructured":"van Dorn A (2020) COVID-19 and readjusting clinical trials. Lancet 396:523\u2013524","journal-title":"Lancet"},{"key":"146_CR16","doi-asserted-by":"crossref","unstructured":"Moher D, Hopewell S, Schulz KF, et al (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340","DOI":"10.3736\/jcim20100801"},{"key":"146_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","volume":"111","author":"GS Murphy","year":"2010","unstructured":"Murphy GS, Brull SJ (2010) Residual neuromuscular block: lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 111:120\u2013128","journal-title":"Anesth Analg"},{"key":"146_CR18","doi-asserted-by":"crossref","unstructured":"Abrishami A, Ho J, Wong J, Yin L, Chung F (2009) Sugammadex , a selective reversal medication for preventing postoperative residual neuromuscular blockade.","DOI":"10.1002\/14651858.CD007362.pub2"},{"key":"146_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012763","author":"AM Hristovska","year":"2017","unstructured":"Hristovska AM, Duch P, Allingstrup M, Afshari A (2017) Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012763","journal-title":"Cochrane Database Syst Rev"},{"key":"146_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5222\/GKDAD.2019.49369","volume":"25","author":"A Baysal \u00c7itil","year":"2019","unstructured":"Baysal \u00c7itil A, Al\u0131c\u0131ku\u015f Tuncel Z, Yap\u0131c\u0131 N, Kudsio\u011flu T, Ayka\u00e7 Z (2019) Kavakl\u0131 AS (2019) Reversal of rocuronium induced neuromuscular blockade in lung resection surgery: a comparison of sugammadex and neostigmine. GKDA Derg 25:23\u201330. https:\/\/doi.org\/10.5222\/GKDAD.2019.49369","journal-title":"GKDA Derg"},{"key":"146_CR21","doi-asserted-by":"crossref","unstructured":"Moon TS, Reznik S, Pak T, et al (2020) Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: a randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period. J Clin Anesth 109804","DOI":"10.1016\/j.jclinane.2020.109804"},{"key":"146_CR22","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1053\/j.jvca.2022.03.033","volume":"36","author":"Y Yu","year":"2022","unstructured":"Yu Y, Wang H, Bao Q, Zhang T, Chen B, Ding J (2022) Sugammadex versus neostigmine for neuromuscular block reversal and postoperative pulmonary complications in patients undergoing resection of lung cancer. J Cardiothorac Vasc Anesth 36:3626\u20133633","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"146_CR23","first-page":"E30876","volume":"101","author":"JL Yang","year":"2022","unstructured":"Yang JL, Chen KB, Shen ML, Hsu WT, Lai YW, Hsu CM (2022) Sugammadex for reversing neuromuscular blockages after lung surgery: a systematic review and meta-analysis. Medicine (United States) 101:E30876","journal-title":"Medicine (United States)"},{"key":"146_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1213\/ANE.0000000000005294","volume":"133","author":"GS Murphy","year":"2021","unstructured":"Murphy GS, Avram MJ, Greenberg SB et al (2021) Neuromuscular and clinical recovery in thoracic surgical patients reversed with neostigmine or sugammadex. Anesth Analg 133:435\u2013444","journal-title":"Anesth Analg"},{"key":"146_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13019-021-01427-9","volume":"16","author":"SW Song","year":"2021","unstructured":"Song SW, Yoo KY, Ro YS, Pyeon T, Bae HB, Kim J (2021) Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study. J Cardiothorac Surg 16:45","journal-title":"J Cardiothorac Surg"},{"key":"146_CR26","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1053\/j.jvca.2023.04.029","volume":"37","author":"F Piccioni","year":"2023","unstructured":"Piccioni F, Langiano N, Bignami E et al (2023) One-lung ventilation and postoperative pulmonary complications after major lung resection surgery. A multicenter randomized controlled trial. J Cardiothorac Vasc Anesth 37:2561\u20132571","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-024-00146-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-024-00146-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-024-00146-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:53:34Z","timestamp":1744170814000},"score":1,"resource":{"primary":{"URL":"https:\/\/janesthanalgcritcare.biomedcentral.com\/articles\/10.1186\/s44158-024-00146-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1186\/s44158-024-00146-6","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Independent Ethics Committee of the Fondazione IRCCS Istituto Nazionale dei Tumori of Milan (Italy). Study number is as follows: INT 91\/14.All patients signed written informed consent before being recruited into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"F. P. and G. D. R. have received fees for teaching and consulting activities from MSD Italia. Other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}